World TB Day 2017: Tuberculosis survivor puts a face on life-threatening disease

Tuberculosis researchers lead scientific workshops for grad students in India

From Colorado to the Amazon rainforest

CSU tuberculosis research team is the largest in US with 170 contributors 

CSU study offers new recommendations for TB vaccine testing in humans

Breakthrough imaging tool maps cells’ composition in 3-D

Powering off TB: New electron transport gene is a potential drug target

Team lands NIH funds to examine tuberculosis and metabolism

Mycobacterium leprae can live for months inside protective hosts amoebae, researchers find

TB infection can spark pre-diabetes, researchers find

Gates Foundation funds a new CSU breath test with promise for diagnosing tuberculosis

Research Led by Colorado State University Reveals Promising Strategy for Treating Tuberculosis

Zoonotic TB research at CSU – Dr. F. Olea-Popelka

Anacor Pharmaceuticals awarded U.S. government funding to discover new classes of systemic antibiotics

CSU researcher and biopharmaceutical company seek tuberculosis treatment

Compound kills drug-resistant tuberculosis through novel mechanism

Collaborative research yields a wiring map on how TB responds to changes in environment

CSU scientists bringing humans, guinea pigs together for TB tests

CSU researchers launch ‘most realistic’ study of how tuberculosis pathogen is transmitted

CSU researchers launch novel investigation into tuberculosis transmission

Leprosy bacterium changed little in last millennium

NPR series on multi-drug resistant tuberculosis (MDR-TB) in Moldova
In the second story, “Moldova Grapples With Whether to Isolate TB Patients”, there is a short segment on the TB patient organization, Speranta Terrei, which MRL Researcher, Asma Henry, helps run in Moldova.

Colorado State University, One of Top TB Research Universities, Commemorates World TB Day with Special Events

CSU Scientist tackling forgotten disease

Tuberculosis Researchers Receive Five Grants to Further Tests, Treatments

Tuberculosis Researchers Find Answer to 30-Year-Old Puzzle

CSU Identifies Anti-TB Compound against Unique Target

Tuberculosis Researchers Discover Potential New Target for Treatments

Researchers Awarded Grant to Investigate Interactions Between Diabetes and Tuberculosis

Dr. Patrick Brennan Receives Distinguished Alumni Award

MIP Researchers Receive FDA Funding to Validate Tuberculosis Treatment Test

Researcher Chosen to Represent North America on World TB Day

MIP Assistant Professor Receives New Innovator Award from NIH